Founders Capital Management Applied Genetic Technologies Corp Transaction History

Founders Capital Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 21, 2022	SELL	$1.87 - $2.91 $5,610 - $8,730	-3,000 Closed	0 $0
Q3 2021 Oct 12, 2021	BUY	$3.01 - $4.12 $9,030 - $12,360	3,000 New	3,000 $9,000
Q4 2020 Jan 12, 2021	SELL	$3.99 - $5.7 $15,960 - $22,800	-4,000 Closed	0 $0
Q1 2020 Apr 22, 2020	SELL	$2.36 - $9.86 $2,360 - $9,860	-1,000 Reduced 20.0%	4,000 $13,000
Q4 2019 Jan 24, 2020	BUY	$2.69 - $4.92 $3,766 - $6,888	1,400 Added 38.89%	5,000 $23,000
Q3 2018 Oct 05, 2018	SELL	$3.85 - $7.35 $1,540 - $2,940	-400 Reduced 10.0%	3,600 $26,000
Q3 2017 Oct 17, 2017	BUY	$3.55 - $5.25 $14,200 - $21,000	4,000	4,000 $16,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Founders Capital Management, based on Form 13F filings with the SEC.

Stay updated on Founders Capital Management with notifications on news.